Sandra Lettlova

Sandra Lettlova

Auto-generated profile, based on publicly available information

Sandra Lettlova

Institute of Biotechnology

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Cell Metabolism
Verified
Journal Article
Closed access
CBClaire L. Bensard
Claire L. Bensard
DWDona R. Wisidagama
Dona R. Wisidagama
KOKristofor A. Olson
Kristofor A. Olson
JBJordan A. Berg
Jordan A. Berg
NKNathan M. Krah
Nathan M. Krah
JRJared Rutter
Jared Rutter

22 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
ZRZuzana Rychtarcikova
Zuzana Rychtarcikova
SLSandra Lettlova
Sandra Lettlova
VTVeronika Tomkova
Veronika Tomkova
VKVlasta Korenkova
Vlasta Korenkova
LLLucie Langerova
Lucie Langerova
Jaroslav TruksaJaroslav Truksa
Jaroslav Truksa
Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism

20 November 2014 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
Marco TomasettiMarco Tomasetti
Marco Tomasetti
LNLinda Nocchi
Linda Nocchi
SSSara Staffolani
Sara Staffolani
NMNicola Manzella
Nicola Manzella
MAMonica Amati
Monica Amati
JNJiri Neuzil
Jiri Neuzil
Aims: MiR126 was found to be frequently lost in many types of cancer, including malignant mesothelioma (MM), which represents one of the most challenging neoplastic diseases. In this study, we investigated the potential tumor suppressor function of MiR126 in MM cells. The effect of MiR126 was examined in response to oxidative stress, aberrant mitochondrial function induced by inhibition of complex I, mitochondrial DNA (mtDNA) depletion, and hypoxia. Results: MiR126 was up-regulated by oxidative stress in nonmalignant mesothelial (Met5A) and MM (H28) cell lines. In Met5A cells, rotenone inhibited MiR126 expression, but mtDNA depletion and hypoxia up-regulated MiR126. However, these various stimuli suppressed the levels of MiR126 in H28 cells. MiR126 affected mitochondrial energy metabolism, reduced mitochondrial respiration, and promoted glycolysis in H28 cells. This metabolic shift, associated with insulin receptor substrate-1 (IRS1)-modulated ATP-citrate lyase deregulation, resulted in higher ATP and citrate production. These changes were linked to the down-regulation of IRS1 by ectopic MiR126, reducing Akt signaling and inhibiting cytosolic sequestration of Forkhead box O1 (FoxO1), which promoted the expression of genes involved in gluconeogenesis and oxidative stress defense. These metabolic changes induced hypoxia-inducible factor-1α (HIF1α) stabilization. Consequently, MiR126 suppressed the malignancy of MM cells in vitro , a notion corroborated by the failure of H28 MiR126 cells to form tumors in nude mice. Innovation and Conclusion: MiR126 affects mitochondrial energy metabolism, resulting in MM tumor suppression. Since MM is a fatal neoplastic disease with a few therapeutic options, this finding is of potential translational importance. Antioxid. Redox Signal. 21, 2109–2125.

5 August 2021 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
ENEsther Nuebel
Esther Nuebel
JMJeffrey T Morgan
Jeffrey T Morgan
SFSarah Fogarty
Sarah Fogarty
JWJacob M Winter
Jacob M Winter
SLSandra Lettlova
Sandra Lettlova
JRJared Rutter
Jared Rutter

7 May 2018 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
SLSandra Lettlova
Sandra Lettlova
VBVeronika Brynychova
Veronika Brynychova
JBJan Blecha
Jan Blecha
DVDavid Vrana
David Vrana
MVMagdalena Vondrusova
Magdalena Vondrusova
Jaroslav TruksaJaroslav Truksa
Jaroslav Truksa
Background/Aims: MiRNA-301a-3p is an oncogenic miRNA whose expression is associated with tumor development, metastases and overall poor prognosis. Estrogen receptor α (ERα) is one of the estrogen hormone-activated transcription factors, which regulates a large number of genes and is involved in the mammary gland development. Expression of ERα is considered to be a good indicator for endocrine therapy and breast cancer survival. Loss of ERα in breast cancer patients indicates invasiveness and poor prognosis. In this study, we focus on the regulation of ERα by miR-301a and its role in transition from estrogen-dependent to estrogen-independent breast cancer. Methods: Expression of miR-301a-3p was measured by qRT-PCR in tumor tissue samples from 111 patients with primary breast carcinoma and in mammospheres representing in vitro model of cancer stem-like cells. Dual reporter luciferase assay and complementary experiments were performed to validate ESR1 as a direct target of miR-301a-3p. The effect of miR-301a-3p on estrogen signaling was evaluated on the level of gene and protein expression and growth response to estrogens. Finally, the effect of miR-301a-3p expression on tumor growth was studied in nude mice. Results: We identified ESR1 as a direct target of miR-301a-3p. Ectopic miR-301a-3p causes a decrease in ESR1 mRNA and protein level and modulates the expression of ERα target genes in ERα positive breast cancer cells. Consistently, miR-301a-3p causes a decrease in sensitivity of MCF7 cells to 17β-estradiol and inhibits the growth of estrogen dependent tumor in nude mice. Yet, the mice tumors have significantly increased expression of genes related to cancer stem-like cells and epithelial to mesenchymal transition suggesting enrichment of the population of cells with more invasive properties, in line with our observation that miR-301a-3p expression is highly increased in mammospheres which show a decrease in estrogenic signaling. Importantly, miR-301a-3P level is also increased in primary breast cancer samples exhibiting an ER/PR negative phenotype. Conclusion: Our results confirm ESR1 as a direct target of miR-301a-3p and suggest that miR-301a-3p likely contributes to development of estrogen independence, which leads to a more invasive phenotype of breast cancer.

10 April 2015 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
Jaroslav TruksaJaroslav Truksa
Jaroslav Truksa
LDLanfeng Dong
Lanfeng Dong
JRJakub Rohlena
Jakub Rohlena
JSJan Stursa
Jan Stursa
MVMagdalena Vondrusova
Magdalena Vondrusova
JNJiri Neuzil
Jiri Neuzil
Aims: To assess the effect of mitochondrially targeted vitamin E (VE) analogs on mitochondrial function and biogenesis. Results: Mitochondrially targeted vitamin E succinate (MitoVES) is an efficient inducer of apoptosis in cancer cells. Here, we show that unlike its untargeted counterpart α-tocopheryl succinate, MitoVES suppresses proliferation of cancer cells at sub-apoptotic doses by way of affecting the mitochondrial DNA (mtDNA) transcripts. We found that MitoVES strongly suppresses the level of the displacement loop transcript followed by those of mtDNA genes coding for subunits of mitochondrial complexes. This process is coupled to the inhibition of mitochondrial respiration, dissipation of the mitochondrial membrane potential, and generation of reactive oxygen species. In addition, exposure of cancer cells to MitoVES led to decreased expression of TFAM and diminished mitochondrial biogenesis. The inhibition of mitochondrial transcription was replicated in vivo in a mouse model of HER2 high breast cancer, where MitoVES lowered the level of mtDNA transcripts in cancer cells but not in normal tissue. Innovation: Our data show that mitochondrially targeted VE analogs represent a novel class of mitocans that not only induce apoptosis at higher concentrations but also block proliferation and suppress normal mitochondrial function and transcription at low, non-apoptogenic doses. Conclusions: Our data indicate a novel, selective anti-cancer activity of compounds that act by targeting mitochondria of cancer cells, inducing significant alterations in mitochondrial function associated with transcription of mtDNA-coded genes. These changes subsequently result in the arrest of cell proliferation. Antioxid. Redox Signal. 22, 883–900.